Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

# Resources

Feminising Adrenal Tumour (Adrenal Gland) – Symptoms, Treatment & Support

What is a Feminising Adrenal Tumour? Feminising adrenal tumours are tumours that result from the uncontrolled division of adrenal cells and are responsible for the overproduction of the hormone estrogen with or without the overproduction of adrenal hormones....

Malignant Ectomesenchymoma – Symptoms, Treatment & Support

What is Malignant Ectomesenchymoma? It is a rare type of rapidly growing tumor in children that arises from the tissues of the nervous system (brain and spinal cord) or soft tissues of the body. It can also affect people aged 60 and over. The most common sites for...

Plexiform Fibrohistiocytic Tumour – Symptoms, Treatment & Support

What is Plexiform Fibrohistiocytic Tumour? Plexiformfibrohistiocytic tumour is a low-grade malignant (cancerous) tumour that usually arises from the soft tissues of the skin of the upper extremities (shoulder, arms, and hands), lower extremities (legs and feet), and...

Precursor B-Lymphoblastic Leukemia – Symptoms, Treatment & Support

What is Precursor B-Lymphoblastic Leukemia? It is an aggressive type of white blood cell cancer (leukemia) in which too many immature B-cells are found in the bone marrow and blood. It is the most prevalent acute lymphoblastic leukemia. It is also known as precursor...

Precursor T-lymphoblastic Leukemia – Symptoms, Treatment & Support

What is Precursor T-lymphoblastic Leukemia? It is an aggressive type of white blood cell cancer (leukemia) in which too many immature T-cells are found in the bone marrow and blood. T cells or T lymphocytes are part of the immune system that fights off infections and...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2026. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter